[go: up one dir, main page]

CN110237134A - A citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells and its preparation method and application - Google Patents

A citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells and its preparation method and application Download PDF

Info

Publication number
CN110237134A
CN110237134A CN201910517901.0A CN201910517901A CN110237134A CN 110237134 A CN110237134 A CN 110237134A CN 201910517901 A CN201910517901 A CN 201910517901A CN 110237134 A CN110237134 A CN 110237134A
Authority
CN
China
Prior art keywords
fructus
freeze
citrus
preparation
fructus fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910517901.0A
Other languages
Chinese (zh)
Inventor
任娇艳
苟娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China University of Technology SCUT
Original Assignee
South China University of Technology SCUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China University of Technology SCUT filed Critical South China University of Technology SCUT
Priority to CN201910517901.0A priority Critical patent/CN110237134A/en
Publication of CN110237134A publication Critical patent/CN110237134A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明公开了一种具有抑制肠癌细胞增殖作用的枳实多酚及其制备方法与应用。该方法包括:将枳实粉碎后,得到枳实粉末,将枳实粉末加入水中,混匀,加热进行提取处理,得到提取液;将提取液离心,取上清液,过滤取滤液,浓缩,干燥得到冻干粉;将冻干粉溶于水中,配制混合液,将大孔树脂加入混合液中,进行吸附处理,抽滤,将吸附后大孔树脂加入乙醇溶液中,置于摇床进行解吸处理,得到解吸液;将解吸液抽滤,取滤液,浓缩,冻干得到所述具有抑制肠癌细胞增殖作用的枳实多酚。本发明提供的枳实提取物具有抑制人结肠癌细胞RKO增殖的活性,可用于制备治疗结肠癌药物的开发,为中药配伍应用于临床抗肿瘤药物研究提供实验基础和科学依据。

The invention discloses a citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells, a preparation method and application thereof. The method comprises: pulverizing Fructus Fructus Fructus Fructus Fructus Fructus Fructus Fructus Aurantii to obtain powder, adding Fructus Fructus Fructus Fructus Fructus Fructus Fructus Fructus Fructus Fructus Powder into water, mixing evenly, and heating for extraction treatment to obtain extract liquid; centrifuging the Fructus Fructus Fructus Fructus Fructus Fructus Fructus Auratus, taking supernatant liquid, filtering to obtain filtrate, concentrating, Dry to obtain freeze-dried powder; dissolve the freeze-dried powder in water, prepare a mixed solution, add the macroporous resin to the mixed solution, perform adsorption treatment, filter with suction, add the adsorbed macroporous resin to the ethanol solution, and place it on a shaker desorption treatment to obtain a desorption solution; the desorption solution is suction-filtered, the filtrate is taken, concentrated, and freeze-dried to obtain the citrus citrus polyphenols that have the effect of inhibiting the proliferation of intestinal cancer cells. The citrus aurantium extract provided by the invention has the activity of inhibiting the proliferation of human colon cancer cells RKO, can be used for the development of drugs for the preparation of colon cancer, and provides an experimental basis and scientific basis for the application of traditional Chinese medicine compatibility in clinical antitumor drug research.

Description

一种具有抑制肠癌细胞增殖作用的枳实多酚及其制备方法与 应用A citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells and its preparation method and application

技术领域technical field

本发明涉及枳实提取技术领域,具体涉及一种具有抑制肠癌细胞增殖作用的枳实多酚及其制备方法与应用。The invention relates to the technical field of citrus aurantium extraction, in particular to a citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells, a preparation method and application thereof.

背景技术Background technique

枳实是芸香科植物酸橙Citrus aurantium L.及其栽培变种或甜橙C.sinensisOsbeck的干燥幼果。《名医别录》有关枳实记载:“除胸胁痰癖,逐停水,破结石,消胀满,心下急痞痛……胁风痛,安胃气,止溏泄”。《神农本草经》谓其:“除寒热结,止痢……”。枳实,其味苦、辛、酸,性微寒,是一种经典理气药,归脾、胃经,具有破气消积、化痰散痞的功效,即枳实具有调畅全身气机,消积滞除痞满的作用,临床广泛应用于治疗积滞内停、痞满胀痛、泻痢后重、大便不通、大便溏薄等症。Citrus aurantium is the dry young fruit of Citrus aurantium L. and its cultivars or sweet orange C. sinensisOsbeck of the Rutaceae plant. "Famous Doctors Bielu" records about Citrus aurantium: "Remove chest and hypophlegm addiction, stop water, break stones, relieve fullness, urgency and pain in the heart...threat wind pain, calm stomach qi, stop diarrhea". "Shen Nong's Materia Medica" said it: "eliminate cold and heat, stop dysentery...". Citrus aurantium, bitter, pungent, sour, slightly cold in nature, is a classic qi-regulating medicine, which belongs to the spleen and stomach meridians, and has the effects of breaking qi and eliminating accumulation, resolving phlegm and dispelling swelling, that is, Citrus aurantium can regulate the whole body's qi , the role of eliminating stagnation and fullness, is widely used clinically to treat stagnant internal stagnation, fullness and pain, heavy diarrhea after diarrhea, obstructed stool, loose stool and other diseases.

药理研究显示,枳实的主要有效成分为黄酮类、挥发油以及少量的生物碱类化合物。柚皮苷、橙皮苷、新橙皮苷等黄酮类最能体现枳实特征,是枳实理气、行滞、平喘、抗炎、抗氧化以及抗过敏的重要活性成分,具有促胃动力的作用,可改善大鼠的胃排空和小肠推进。生物碱类为枳实中强心升压的主要成分,主要有辛弗林、N-甲基酪胺、乙酰去甲辛弗林、去甲肾上腺素、喹诺啉、那可汀等。枳实始载于《神农本草经》,列为中品,其味苦、辛,微寒,归脾、胃、大肠经,具有破气消积、化痰除痞之功效。Pharmacological studies have shown that the main active ingredients of Citrus aurantium are flavonoids, volatile oil and a small amount of alkaloids. Flavonoids such as naringin, hesperidin, and neohesperidin can best reflect the characteristics of Citrus aurantii, and are important active ingredients of Citrus Citrus Citrus to regulate qi, stagnation, relieve asthma, anti-inflammation, anti-oxidation and anti-allergy, and have gastric motility Improves gastric emptying and intestinal propulsion in rats. Alkaloids are the main components of Cardiac Boost in Aurantium citrifolia, mainly synephrine, N-methyltyramine, acetyl norsynephrine, norepinephrine, quinoline, narcotine, etc. Citrus aurantium was first recorded in "Shen Nong's Materia Medica", and was listed as a middle grade. It tastes bitter, pungent, slightly cold, and returns to the spleen, stomach, and large intestine meridian.

枳实治积冷利脱肛:枳实一枚。石上磨令滑泽,钻安柄,蜜涂、炙令暖熨之,冷更易之,取缩入止。(《干金方》);枳实治产后腹痛,烦满不得卧:枳实(烧令黑,匆太过)、芍药等分。杵为散。服方寸匕,日三服。并主痈脓,以麦粥下之。(《金匮要略》)枳实芍药散);治大便不通:枳实、皂荚等分。(《世医得效方》)。Citrus aurantium treats accumulated cold and prolapse of the anus: one piece of Citrus aurantium. Grind on the stone to make it smooth, drill it to install the handle, apply it with honey, and burn it to make it warm and iron it. ("Dry Gold Prescription"); Aurantium citrifolia treats postpartum abdominal pain, and you can't lie down when you are full: citrus aurantium (burning black, too much haste), and peony are divided into equal parts. The pestle is scattered. Take a square-inch dagger, three times a day. And the main carbuncle pus, with wheat porridge. ("Synopsis of the Golden Chamber" Citrus aurantium and Shaoyao powder); treat constipation: Divide aurantium citrus and acacia in equal parts. ("Shi Yi De Xiao Fang").

大肠癌(colorectal cancer,CRC)是最常见的恶性肿瘤之一,发病率居第3位,是主要的癌症相关死亡原因。根据世界卫生组织发布的消息,2015年全球因大肠癌导致死亡的人数为77.4万人;在我国,大肠癌的发病率呈明显的上升趋势,死亡率位居恶性肿瘤死因的第2位。Colorectal cancer (CRC) is one of the most common malignant tumors, ranking third in incidence and the leading cause of cancer-related death. According to the information released by the World Health Organization, the number of deaths caused by colorectal cancer in the world in 2015 was 774,000; in my country, the incidence of colorectal cancer shows a clear upward trend, and the mortality rate ranks second in the cause of death from malignant tumors.

研究表明枳实对胃肠具有一定的保护作用,枳实、枳壳的水煎剂、酊剂及流浸膏对小鼠、家兔的离体肠管及家兔的在体肠管均有抑制作用。水煎液使胃、肠瘘狗的胃肠收缩节律有力,呈兴奋作用。枳实提取物对乙酰胆碱和组胺所致肠管收缩有明显的拮抗作用。Studies have shown that Fructus Aurantium has a certain protective effect on the gastrointestinal tract, and decoctions, tinctures and liquid extracts of Fructus Fructus Fructus Aurantium and Fructus Aurantium have inhibitory effects on the isolated intestines of mice and rabbits and the intestines of rabbits in vivo. The water decoction can make the gastrointestinal contraction rhythm of dogs with gastric and intestinal fistula strong, showing excitatory effect. Citrus aurantium extract has obvious antagonistic effect on intestinal contraction induced by acetylcholine and histamine.

现有枳实多酚制备工艺方法陈旧,一般由枳实药材经过简单提取后所得粗提物制备而成,有效成分含量低;表明本发明采用新方法对枳实多酚进行提取、分离,通过大孔树脂富集提取物中的有效成分,提高了枳实原料的有效利用率。The existing method for preparing polyphenols from Citrus Citrus is outdated, and is generally prepared from the crude extract obtained after simple extraction of Citrus Citrus medicinal materials, and the content of active ingredients is low; it shows that the present invention adopts a new method to extract and separate polyphenols from Citrus Citrus. The macroporous resin enriches the effective components in the extract, which improves the effective utilization rate of the raw materials of Citrus aurantium.

发明内容Contents of the invention

为了克服现有技术存在的上述不足,本发明的目的是提供一种具有抑制肠癌细胞增殖作用的枳实多酚及其制备方法与应用。In order to overcome the above-mentioned deficiencies in the prior art, the object of the present invention is to provide a citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells, its preparation method and application.

本发明提供枳实提取物在制备抑制肠癌细胞增殖中药提取物中的应用,能够从枳实原料中提取、富集有效抑制肠癌细胞增殖的活性成分,实现枳实提取物的新用途问题。The invention provides the application of Citrus aurantium extract in the preparation of traditional Chinese medicine extracts for inhibiting the proliferation of intestinal cancer cells, which can extract and enrich the active ingredients that can effectively inhibit the proliferation of intestinal cancer cells from the raw materials of Citrus aurantium, and realize the new application of Citrus citrus extract .

本发明的目的至少通过如下技术方案之一实现。The object of the present invention is achieved at least by one of the following technical solutions.

本发明提供的一种具有抑制肠癌细胞增殖作用的枳实多酚的制备方法,包括如下步骤:A method for preparing Citrus citrus polyphenols with the effect of inhibiting the proliferation of intestinal cancer cells provided by the present invention comprises the following steps:

(1)将干燥的药材枳实粉碎后过筛,得到枳实粉末,将所述枳实粉末加水浸提,混合均匀,加热进行提取处理,得到提取液;(1) crushing and sieving the dried medicinal material Fructus Fructus Fructus Fructus Fructus Aurantium, adding water to extract the Fructus Fructus Fructus Fructus Fructus Medicae powder, mixing evenly, heating for extraction treatment, and obtaining an extract;

(2)将步骤(1)所述提取液进行离心处理,取上清液,过滤取滤液,浓缩,冷冻干燥得到冻干粉;(2) centrifuging the extract described in step (1), taking the supernatant, filtering to get the filtrate, concentrating, and freeze-drying to obtain freeze-dried powder;

(3)将步骤(2)所述冻干粉加入去离子水中(复溶),混合均匀,得到混合液,将大孔树脂加入混合液中(大孔树脂静态吸附),进行吸附处理,抽滤取滤渣,将滤渣加入乙醇溶液中(利用乙醇溶液解吸大孔树脂中所吸附的物质),置于摇床中进行解吸处理,得到解吸液;(3) Add the freeze-dried powder described in step (2) into deionized water (redissolution), mix evenly to obtain a mixed solution, add the macroporous resin into the mixed solution (macroporous resin static adsorption), carry out adsorption treatment, pump Filter the filter residue, add the filter residue to the ethanol solution (use the ethanol solution to desorb the substance adsorbed in the macroporous resin), place it in a shaker for desorption treatment, and obtain a desorption solution;

(4)将步骤(3)所述解吸液抽滤,取滤液,浓缩,冷冻干燥得到粉末,即所述具有抑制肠癌细胞增殖作用的枳实多酚。冷冻干燥得到的粉末中枳实多酚含量为55.92%-63.27%。(4) Suction filter the desorption liquid in step (3), take the filtrate, concentrate, and freeze-dry to obtain powder, that is, the aurantia citrus polyphenols that have the effect of inhibiting the proliferation of intestinal cancer cells. The polyphenol content in the powder obtained by freeze-drying is 55.92%-63.27%.

可将所述具有抑制肠癌细胞增殖作用的枳实多酚复溶,经CCK8实验探究枳实提取物对RKO细胞增殖抑制作用。The citrus citrus polyphenols that have the effect of inhibiting the proliferation of intestinal cancer cells can be redissolved, and the inhibitory effect of citrus citrus extract on the proliferation of RKO cells can be explored by CCK8 experiment.

进一步地,步骤(1)所述过筛的筛孔大小为20-100目;步骤(1)所述水的质量为枳实粉末质量的10-20倍;步骤(1)所述加热进行提取处理的温度为60-80℃,所述加热进行提取处理的时间为1-3h。Further, the sieve size of the sieve in the step (1) is 20-100 mesh; the quality of the water in the step (1) is 10-20 times that of the Fructus Citrifolia powder mass; the heating in the step (1) is carried out to extract The temperature of the treatment is 60-80° C., and the heating time for the extraction treatment is 1-3 hours.

优选地,所述提取处理,可以进行多次提取,第一次提取处理,固液分离,得到第一次提取液与第一次滤渣,将第一次滤渣重新加入水中,重新加热至60-80℃,加热时间为1-3h,进行下一轮提取,固液分离,然后得到第二次提取液与第二次滤渣;以此类推,可以反复对枳实粉末进行提取,充分利用枳实粉末中的有效成分,然后将提取液合并再进行下一步骤;所述提取处理的次数为1-3次。Preferably, the extraction process can be extracted multiple times, the first extraction process is solid-liquid separation, the first extraction liquid and the first filter residue are obtained, the first filter residue is added to the water, and reheated to 60- 80°C, heating time is 1-3h, carry out the next round of extraction, solid-liquid separation, and then obtain the second extraction liquid and the second filter residue; and so on, can repeatedly extract the citrus aurantium powder, make full use of citrus aurantium The active ingredients in the powder, and then the extraction solution is combined before proceeding to the next step; the number of times of the extraction treatment is 1-3 times.

进一步地,步骤(2)所述离心处理的速率为2000-8000rpm,离心处理的时间为10-15min,所述离心处理的温度为2-6℃;步骤(2)所述过滤为将上清液过60目的尼龙滤布。优选地,所述将上清液过60目的尼龙滤布,尼龙滤布的层数为4层。Further, the speed of the centrifugal treatment in step (2) is 2000-8000rpm, the time of the centrifugal treatment is 10-15min, and the temperature of the centrifugal treatment is 2-6°C; the filtration in the step (2) is the supernatant The liquid passes through a 60-mesh nylon filter cloth. Preferably, the supernatant is passed through a 60-mesh nylon filter cloth, and the number of layers of the nylon filter cloth is 4 layers.

进一步地,步骤(2)所述浓缩的方式包括旋转蒸发,所述旋转蒸发的温度为50-65℃;步骤(2)所述冷冻干燥为真空冷冻干燥,冷冻干燥的时间为24-48h。Further, the method of concentration in step (2) includes rotary evaporation, and the temperature of the rotary evaporation is 50-65°C; the freeze-drying in step (2) is vacuum freeze-drying, and the freeze-drying time is 24-48h.

进一步地,步骤(3)所述冻干粉与去离子水的质量体积比为40-60mg/mL;步骤(3)所述大孔树脂的型号包括AB-8、ADS-17、D101及NKA-9等;所述大孔树脂干基与混合液的质量体积比为1:10-1:20g/mL。Further, the mass volume ratio of the lyophilized powder and deionized water in step (3) is 40-60 mg/mL; the models of the macroporous resin in step (3) include AB-8, ADS-17, D101 and NKA -9, etc.; the mass volume ratio of the dry base of the macroporous resin to the mixed solution is 1:10-1:20g/mL.

进一步地,步骤(3)所述吸附处理是在摇床中进行的,所述摇床的转速为50-200rpm;所述吸附处理的时间为3-15h,吸附处理的温度为20-25℃。Further, the adsorption treatment in step (3) is carried out in a shaking table, the rotating speed of the shaking table is 50-200rpm; the time of the adsorption treatment is 3-15h, and the temperature of the adsorption treatment is 20-25°C .

进一步地,步骤(3)所述乙醇溶液体积分数为80%-95%,;所述置于摇床中进行解吸处理的摇床转速为50-200rpm;所述解吸处理的温度为20-25℃,解吸处理的时间为3-12h。Further, the volume fraction of the ethanol solution in step (3) is 80%-95%; the rotating speed of the shaking table placed in the shaking table for desorption treatment is 50-200rpm; the temperature of the desorption treatment is 20-25 ℃, the desorption treatment time is 3-12h.

进一步地,步骤(4)所述浓缩的方式包括旋转蒸发。Further, the method of concentrating in step (4) includes rotary evaporation.

本发明提供的具有抑制肠癌细胞增殖作用的枳实多酚能够应用在制备抑制肠癌细胞(RKO)增殖的药物中。The citrus citrus polyphenols provided by the invention with the effect of inhibiting the proliferation of intestinal cancer cells can be used in the preparation of drugs for inhibiting the proliferation of intestinal cancer cells (RKO).

本发明提供的具有抑制肠癌细胞增殖作用的枳实多酚经福林酚法多酚定量后,按照一定浓度添加至含10%FBS的DMEM细胞培养基中,可用于测定枳实提取物对肠癌细胞RKO的增殖抑制效果。The citrus citrus polyphenols provided by the present invention have the effect of inhibiting the proliferation of intestinal cancer cells. After the polyphenols are quantified by the Folin phenol method, they are added to the DMEM cell culture medium containing 10% FBS according to a certain concentration, which can be used to determine the effect of citrus citrus extract on Proliferation inhibitory effect of intestinal cancer cell RKO.

本发明通过CCK8抑制肠癌RKO细胞增殖作用实验验证,枳实粗提物冻干粉A中多酚含量需达到250μg/mL才能抑制50%以上肠癌细胞增殖;通过本发明制备的乙醇解吸AB-8吸附的部分冻干粉C,其多酚含量达到160μg/mL就能抑制50%以上肠癌细胞增殖。实验结果表明经AB-8大孔树脂吸附处理枳实提取物药效比未处理的中药枳实提取物效果好。The present invention is verified by CCK8 inhibition of intestinal cancer RKO cell proliferation experiment, the polyphenol content in the crude extract freeze-dried powder A of Citrus aurantii must reach 250 μg/mL to inhibit the proliferation of more than 50% of intestinal cancer cells; the ethanol desorption AB prepared by the present invention Part of the freeze-dried powder C adsorbed by -8, the polyphenol content of which reaches 160 μg/mL can inhibit the proliferation of more than 50% of intestinal cancer cells. The experimental results showed that the efficacy of Aurantium citrus extract treated with AB-8 macroporous resin was better than that of untreated traditional Chinese medicine citrus citrus extract.

与现有技术相比,本发明具有如下优点和有益效果:Compared with the prior art, the present invention has the following advantages and beneficial effects:

(1)本发明提供的制备方法步骤简单,经AB-8大孔树脂吸附并经乙醇解吸后,得到的枳实提取物具有抑制肠癌细胞的功效,可用于制备治疗肠癌的中药提取物,开拓了治疗肠癌中药原料的新途径,有一定的经济效益和社会效益。(1) The preparation method provided by the present invention has simple steps. After being adsorbed by AB-8 macroporous resin and desorbed by ethanol, the obtained Citrus aurantium extract has the effect of inhibiting intestinal cancer cells, and can be used to prepare a Chinese medicine extract for the treatment of intestinal cancer , opened up a new approach to the treatment of intestinal cancer raw materials of traditional Chinese medicine, there are certain economic and social benefits.

附图说明Description of drawings

图1为实施例5中冻干粉A组、冻干粉B组、冻干粉C组物质(多酚定量)对人结肠癌RKO细胞增殖的影响柱状图;Fig. 1 is the histogram of the effect of freeze-dried powder group A, freeze-dried powder group B, and freeze-dried powder C group substances (polyphenol quantification) on the proliferation of human colon cancer RKO cells in Example 5;

图2为实施例5中不同浓度下枳实提取物对人结肠癌RKO细胞形态的影响,倒置显微镜(奥特光学BDS200)观察图(放大倍数为20倍)。Fig. 2 is the influence of Fructus Fructus Citrus Fructus extract at different concentrations on the morphology of human colon cancer RKO cells in Example 5, observed under an inverted microscope (Aoto Optical BDS200) (magnification is 20 times).

具体实施方式Detailed ways

以下结合附图和实例对本发明的具体实施作进一步说明,但本发明的实施和保护不限于此。需指出的是,以下若有未特别详细说明之过程,均是本领域技术人员可参照现有技术实现或理解的。所用试剂或仪器未注明生产厂商者,视为可以通过市售购买得到的常规产品。The specific implementation of the present invention will be further described below in conjunction with the accompanying drawings and examples, but the implementation and protection of the present invention are not limited thereto. It should be pointed out that, if there are any processes in the following that are not specifically described in detail, those skilled in the art can realize or understand with reference to the prior art. The reagents or instruments used were not indicated by the manufacturer, and they were regarded as conventional products that can be purchased from the market.

实施例1Example 1

一种具有抑制肠癌细胞增殖作用的枳实多酚的制备方法,包括如下步骤:A method for preparing citrus citrus polyphenols with the effect of inhibiting the proliferation of intestinal cancer cells, comprising the steps of:

(1)将药材枳实粉碎后过20目筛,得到枳实粉末,将所述10g枳实粉末加入200mL去离子水中,混合均匀,加热进行两次提取处理,提取处理的温度为80℃,提取处理的时间为1h,合并2次提取产物,得到提取液;(1) After crushing the medicinal material Fructus Fructus Fructus Aurantii, pass through a 20-mesh sieve to obtain Fructus Fructus Fructus Fructus Fructus Fructus Powder, add described 10g Fructus Fructus Fructus Fructus Fructus Fructus Fructus Powder into 200mL deionized water, mix evenly, heat and carry out extraction processing twice, the temperature of extraction processing is 80 ℃, The time for the extraction treatment is 1 hour, and the two extraction products are combined to obtain the extract;

(2)将步骤(1)所述提取液进行离心处理(2℃、2000rpm离心10min),取上清液,过4层60目尼龙滤布收集滤液,50℃旋转蒸发浓缩,真空冷冻干燥得到冻干粉;(2) Centrifuge the extract described in step (1) (2°C, 2000rpm for 10min), take the supernatant, pass through 4 layers of 60-mesh nylon filter cloth to collect the filtrate, concentrate by rotary evaporation at 50°C, and vacuum freeze-dry to obtain freeze-dried powder;

(3)将步骤(2)所述冻干粉加入20mL去离子水中,混合均匀,配制成混合液(冻干粉在混合液中的浓度为50mg/mL),大孔树脂AB-8干基(已活化)按照质量体积比为1:10g/mL加入所述混合液中,进行静态吸附处理,吸附处理是在摇床中进行的,摇床的转速为200rpm,吸附处理的温度为25℃,吸附处理的时间为15h,抽滤分离滤液与滤渣(滤渣为吸附后的大孔树脂),将滤渣加入20mL体积分数为95%的乙醇溶液中,置于摇床中进行解吸处理,摇床的转速为200rpm,解吸处理的温度为25℃,解吸处理的时间为12h,得到解吸液;(3) Add the freeze-dried powder described in step (2) into 20 mL of deionized water, mix well, and prepare a mixed solution (the concentration of the freeze-dried powder in the mixed solution is 50 mg/mL), macroporous resin AB-8 dry basis (Activated) according to the mass volume ratio of 1:10g/mL added to the mixed solution for static adsorption treatment, the adsorption treatment is carried out in a shaking table, the rotating speed of the shaking table is 200rpm, and the temperature of the adsorption treatment is 25°C , the time of adsorption treatment is 15h, suction filtration separates filtrate and filter residue (filter residue is the macroporous resin after adsorption), and filter residue is added in 20mL ethanol solution that volume fraction is 95%, is placed in shaker and carries out desorption process, shaker The rotating speed is 200rpm, the temperature of the desorption treatment is 25°C, the time of the desorption treatment is 12h, and the desorption liquid is obtained;

(4)将步骤(3)所述解吸液抽滤,取滤液,蒸发浓缩,冷冻干燥得到冻干粉末,冻干粉末中含有所述具有抑制肠癌细胞增殖作用的枳实多酚(枳实多酚总量为83.33mg)。(4) suction filter the desorption liquid described in step (3), take the filtrate, evaporate and concentrate, and freeze-dry to obtain a freeze-dried powder. The total amount of polyphenols is 83.33mg).

实施例2Example 2

一种具有抑制肠癌细胞增殖作用的枳实多酚的制备方法,包括如下步骤:A method for preparing citrus citrus polyphenols with the effect of inhibiting the proliferation of intestinal cancer cells, comprising the steps of:

(1)将药材枳实粉碎后过50目筛,得到枳实粉末,将所述10g枳实粉末加入120mL去离子水中,混合均匀,加热进行3次提取处理,提取处理的温度为70℃,提取处理的时间为2h,合并3次提取产物,得到提取液;(1) After crushing the medicinal material Fructus Fructus Fructus Aurantii, pass through a 50-mesh sieve to obtain Fructus Fructus Fructus Fructus Fructus Fructus Powder, add described 10g Fructus Fructus Fructus Fructus Fructus Fructus Fructus Powder into 120mL deionized water, mix evenly, heat and carry out extraction treatment 3 times, the temperature of extraction treatment is 70 ℃, The extraction treatment time is 2 hours, and the extraction products are combined three times to obtain the extract;

(2)将步骤(1)所述提取液进行离心处理(4℃、5000rpm离心13min),取上清液,过4层60目尼龙滤布收集滤液,60℃旋转蒸发浓缩,真空冷冻干燥得到冻干粉;(2) Centrifuge the extract described in step (1) (4 °C, 5000 rpm for 13 min), take the supernatant, pass through 4 layers of 60-mesh nylon filter cloth to collect the filtrate, concentrate by rotary evaporation at 60 °C, and vacuum freeze-dry to obtain freeze-dried powder;

(3)将步骤(2)所述冻干粉加入20mL去离子水中,配制成混合液(在混合液中,冻干粉的浓度为50mg/mL),非极性大孔树脂D101干基(已活化)按照质量体积比为1:12g/mL加入所述混合液中,进行静态吸附处理,吸附处理是在摇床中进行的,摇床的转速为100rpm,吸附处理的温度为23℃,吸附处理的时间为10h,抽滤分离滤液与滤渣(滤渣为吸附后的大孔树脂),将滤渣加入20mL体积分数为80%的乙醇溶液中,置于摇床中进行解吸处理,摇床的转速为100rpm,解吸处理的温度为23℃,解吸处理的时间为6h,得到解吸液;(3) Add the freeze-dried powder described in step (2) into 20mL deionized water to prepare a mixed solution (in the mixed solution, the concentration of the freeze-dried powder is 50 mg/mL), non-polar macroporous resin D101 dry basis ( Activated) was added to the mixed solution according to the mass volume ratio of 1:12g/mL for static adsorption treatment. The adsorption treatment was carried out in a shaking table, the rotating speed of the shaking table was 100rpm, and the temperature of the adsorption treatment was 23°C. The time of adsorption treatment is 10h, and suction filtration separates filtrate and filter residue (filter residue is the macroporous resin after adsorption), and filter residue is added in 20mL volume fraction and is 80% ethanol solution, is placed in shaker and carries out desorption process, shaker The rotating speed is 100rpm, the temperature of desorption treatment is 23°C, and the time of desorption treatment is 6h, and the desorption liquid is obtained;

(4)将步骤(3)所述解吸液抽滤,取滤液,蒸发浓缩,冷冻干燥得到冻干粉末,冻干粉末中含有所述具有抑制肠癌细胞增殖作用的枳实多酚(枳实多酚总量为51.15mg)。(4) suction filter the desorption liquid described in step (3), take the filtrate, evaporate and concentrate, and freeze-dry to obtain a freeze-dried powder. The total amount of polyphenols is 51.15mg).

实施例3Example 3

一种具有抑制肠癌细胞增殖作用的枳实多酚的制备方法,包括如下步骤:A method for preparing citrus citrus polyphenols with the effect of inhibiting the proliferation of intestinal cancer cells, comprising the steps of:

(1)将药材枳实粉碎后过100目筛,得到枳实粉末,将所述10g枳实粉末加入100mL去离子水中,混合均匀,加热进行2次提取处理,提取处理的温度为60℃,提取处理的时间为1.5h,合并2次提取产物,得到提取液;(1) After crushing the medicinal material Fructus Fructus Fructus Fructus Aurantii, pass through a 100-mesh sieve to obtain Fructus Fructus Fructus Fructus Fructus Fructus Citrifolia powder, add described 10g Fructus Fructus Fructus Fructus Fructus Fructus Fructus Powder into 100mL deionized water, mix evenly, heat and carry out extraction treatment twice, the temperature of extraction processing is 60 ℃, The time of extraction treatment is 1.5h, and the two extraction products are combined to obtain the extract;

(2)将步骤(1)所述提取液进行离心处理(4℃、5000rpm离心15min),取上清液,过4层60目尼龙滤布收集滤液,55℃旋转蒸发浓缩,真空冷冻干燥得到冻干粉;(2) Centrifuge the extract described in step (1) (4 °C, 5000 rpm for 15 min), take the supernatant, pass through 4 layers of 60-mesh nylon filter cloth to collect the filtrate, concentrate by rotary evaporation at 55 °C, and vacuum freeze-dry to obtain freeze-dried powder;

(3)将步骤(2)所述冻干粉加入20mL去离子水中,混合均匀,配制成混合液(在混合液中冻干粉的浓度为40mg/mL),按照弱极性大孔树脂ADS-17干基(已活化)与混合液的质量体积比为1:20g/mL,将大孔树脂ADS-17干基加入混合液中,进行静态吸附处理,吸附处理是在摇床中进行的,摇床的转速为50rpm,吸附处理的温度为20℃,吸附处理的时间为10h,抽滤分离滤液与滤渣(滤渣为吸附后的大孔树脂),将滤渣加入20mL体积分数为80%的乙醇溶液中,置于摇床中进行解吸处理,摇床的转速为50rpm,解吸处理的温度为25℃,解吸处理的时间为3h,得到解吸液;(3) Add the freeze-dried powder described in step (2) into 20 mL of deionized water, mix well, and prepare a mixed solution (the concentration of the freeze-dried powder in the mixed solution is 40 mg/mL), and follow the weak polarity macroporous resin ADS The mass volume ratio of -17 dry base (activated) to the mixed solution is 1:20g/mL, add the dry base of macroporous resin ADS-17 into the mixed solution for static adsorption treatment, and the adsorption treatment is carried out in a shaking table , the rotating speed of shaking table is 50rpm, the temperature of adsorption treatment is 20 ℃, the time of adsorption treatment is 10h, suction filtration separates filtrate and filter residue (filter residue is the macroporous resin after adsorption), and filter residue is added into 20mL volume fraction is 80% In the ethanol solution, place it in a shaking table for desorption treatment, the rotation speed of the shaking table is 50 rpm, the temperature of the desorption treatment is 25 ° C, and the time of the desorption treatment is 3 hours, to obtain the desorption solution;

(4)将步骤(3)所述解吸液抽滤,取滤液,蒸发浓缩,冷冻干燥得到冻干粉末,冻干粉末中含有所述具有抑制肠癌细胞增殖作用的枳实多酚(枳实多酚总量为67.04mg)。(4) suction filter the desorption liquid described in step (3), take the filtrate, evaporate and concentrate, and freeze-dry to obtain a freeze-dried powder. The total amount of polyphenols is 67.04mg).

实施例4Example 4

一种具有抑制肠癌细胞增殖作用的枳实多酚的制备方法,包括如下步骤:A method for preparing citrus citrus polyphenols with the effect of inhibiting the proliferation of intestinal cancer cells, comprising the steps of:

(1)将药材枳实粉碎后过80目筛,得到枳实粉末,将所述10g枳实粉末加入150mL去离子水中,混合均匀,加热进行2次提取处理,提取处理的温度为75℃,提取处理的时间为2h,合并2次提取产物,得到提取液;(1) After crushing the medicinal material Fructus Fructus Fructus Fructus Aurantii, pass through 80 mesh sieves to obtain Fructus Fructus Fructus Fructus Fructus Fructus Fructus Powder, add described 10g Fructus Fructus Fructus Fructus Fructus Fructus Fructus Powder into 150mL deionized water, mix evenly, heat and carry out 2 times of extraction treatment, the temperature of extraction treatment is 75 ℃, The time for the extraction treatment is 2 hours, and the two extraction products are combined to obtain the extract;

(2)将步骤(1)所述提取液进行离心处理(4℃、5000rpm离心15min),取上清液,过4层60目尼龙滤布收集滤液,65℃旋转蒸发浓缩,真空冷冻干燥得到冻干粉;(2) Centrifuge the extract described in step (1) (4 °C, 5000 rpm for 15 min), take the supernatant, pass through 4 layers of 60-mesh nylon filter cloth to collect the filtrate, concentrate by rotary evaporation at 65 °C, and vacuum freeze-dry to obtain freeze-dried powder;

(3)将步骤(2)所述冻干粉加入20mL去离子水中,混合均匀,配制成混合液(在混合液中冻干粉的浓度为60mg/mL),按照极性大孔树脂NKA-9干基(已活化)与混合液的质量体积比为1:16g/mL,将极性大孔树脂NKA-9干基加入所述混合液中,进行静态吸附处理,吸附处理是在摇床中进行的,摇床的转速为120rpm(吸附处理的温度为25℃,吸附处理的时间为8h,抽滤分离滤液与滤渣(滤渣为吸附后的大孔树脂),将滤渣加入20mL体积分数为92%的乙醇溶液中,置于摇床中进行解吸处理,摇床的转速为120rpm,解吸处理的温度为20℃,解吸处理的时间为12h,得到解吸液;(3) Add the freeze-dried powder described in step (2) into 20 mL of deionized water, mix well, and prepare a mixed solution (the concentration of the freeze-dried powder in the mixed solution is 60 mg/mL), according to the polar macroporous resin NKA- 9 The mass volume ratio of the dry base (activated) to the mixed solution is 1:16g/mL, and the polar macroporous resin NKA-9 dry base is added to the mixed solution for static adsorption treatment. carried out in , the rotating speed of the shaker was 120rpm (the temperature of the adsorption treatment was 25°C, the time of the adsorption treatment was 8h, the filtrate and the filter residue were separated by suction filtration (the filter residue was the macroporous resin after adsorption), and the filter residue was added to 20mL with a volume fraction of 92% ethanol solution, placed in a shaker for desorption treatment, the rotation speed of the shaker is 120rpm, the temperature of the desorption treatment is 20°C, and the time of the desorption treatment is 12h, to obtain the desorption solution;

(4)将步骤(3)所述解吸液抽滤,取滤液,蒸发浓缩,冷冻干燥得到冻干粉末,冻干粉末中含有所述具有抑制肠癌细胞增殖作用的枳实多酚(枳实多酚总量为54.35mg)。(4) suction filter the desorption liquid described in step (3), take the filtrate, evaporate and concentrate, and freeze-dry to obtain a freeze-dried powder. The total amount of polyphenols is 54.35mg).

实施效果验证Implementation effect verification

以上提供了4例实施方案,这4例实施方案分别采用了不同的大孔树脂,以下结合相关公式及数据,探究4种大孔树脂中对枳实活性成分的吸附率和解吸率。The above provides 4 examples of implementation schemes. These 4 examples of implementation schemes use different macroporous resins respectively. The following combines relevant formulas and data to explore the adsorption and desorption rates of the active ingredients of Fructus Aurantium Fructus in the 4 kinds of macroporous resins.

根据下列公式计算不同树脂的吸附和解吸率(可参考文献《侧柏叶多酚的分离纯化、结构鉴定及相关活性研究》)。Calculate the adsorption and desorption rates of different resins according to the following formula (refer to the literature "Isolation, Purification, Structure Identification and Related Activity Research of Arborvitae Leaf Polyphenols").

多酚吸附率R1(%)=(C0-Ce)/C0*100;Polyphenol adsorption rate R1(%)=(C0-Ce)/C0*100;

树脂解吸率R2(%)=Cd*V2/(Qe*m)*100;Resin desorption rate R2(%)=Cd*V2/(Qe*m)*100;

树脂吸附量Qe(mg/g)=(C0-Ce)*V0/m;Resin adsorption capacity Qe(mg/g)=(C0-Ce)*V0/m;

树脂解吸量D(mg/g)=Cd*V2/m;Resin desorption amount D(mg/g)=Cd*V2/m;

其中,C0:步骤(1)所述的提取液中多酚浓度,mg/mL;Wherein, C0: polyphenol concentration in the extract described in step (1), mg/mL;

Ce:步骤(3)所述吸附处理后,抽滤得到的吸附平衡后滤液中多酚的浓度,mg/mL;Ce: after the adsorption treatment described in step (3), the concentration of polyphenols in the filtrate obtained by suction filtration after adsorption equilibrium, mg/mL;

R1:吸附率,100%;R1: adsorption rate, 100%;

Qe:吸附量,mg/g;Qe: adsorption capacity, mg/g;

V0:加样体积,mL;V0: sample volume, mL;

M:树脂质量,g;M: Resin mass, g;

R2:解吸率,100%;R2: Desorption rate, 100%;

D:解吸量,mg/g;D: desorption amount, mg/g;

Cd:步骤(4)所述解吸液抽滤后得到的解吸平衡后滤液中多酚浓度,mg/mL;Cd: the concentration of polyphenols in the filtrate obtained after desorption equilibrium obtained after the desorption solution described in step (4), mg/mL;

V2:解吸液体积,mL;V2: volume of desorption solution, mL;

4种大孔树脂中对枳实活性成分的吸附率和解吸率测试结果见于下表1,表1为4种大孔树脂吸附率和解吸率测试数据表。The test results of the adsorption rate and desorption rate of the active ingredients of Aurantium Fructus Fructus Fructus Fructus in 4 kinds of macroporous resins are shown in the following table 1, and table 1 is the test data table of the adsorption rate and desorption rate of 4 kinds of macroporous resins.

表1Table 1

综合上述4例实施方案,这4种大孔树脂中对枳实活性成分的吸附率和解吸率最大的都是AB-8树脂(实施例1),说明弱极性的AB-8大孔树脂对枳实活性成分吸附和解吸的能力都是最强的。综合考虑吸附率和解吸率,选择吸附率为63.27%,解吸率为96.33%的AB-8大孔树脂,作为后续实验中制备抑制肠癌细胞增殖受试物的树脂。Comprehensive above-mentioned 4 example embodiments, in these 4 kinds of macroporous resins, the adsorption rate and the desorption rate to the Fructus Fructus Aurantii active ingredient are maximum all is AB-8 resin (embodiment 1), illustrate the AB-8 macroporous resin of weak polarity The ability to adsorb and desorb the active ingredients of Citrus aurantium is the strongest. Considering the adsorption rate and desorption rate comprehensively, the AB-8 macroporous resin with an adsorption rate of 63.27% and a desorption rate of 96.33% was selected as the resin for preparing the test substance for inhibiting intestinal cancer cell proliferation in subsequent experiments.

将实施例1提供的制备方法中步骤(2)所述冻干粉命名为冻干粉A;将实施例1提供的制备方法中步骤(3)所述抽滤分离滤液与滤渣,得到的滤液,进行冷冻干燥处理,得到的粉末命名为冻干粉B;将实施例1提供的制备方法中步骤(4)所述具有抑制肠癌细胞(RKO)增殖作用的枳实多酚,命名为冻干粉C。进行CCK8实验,以探究这三种枳实提取物(冻干粉A、冻干粉B及冻干粉C)对RKO细胞增殖抑制作用。The freeze-dried powder described in step (2) in the preparation method provided by Example 1 is named as freeze-dried powder A; the described suction filtration of step (3) in the preparation method provided by Example 1 separates the filtrate and the filter residue, and the obtained filtrate , carry out freeze-drying treatment, and the powder obtained is named as freeze-dried powder B; the polyphenols of Fructus Fructus Fructus Fructus Fructus Fructus Polyphenols described in step (4) in the preparation method provided by Example 1, which has the effect of inhibiting the proliferation of intestinal cancer cells (RKO), are named as freeze-dried powder B. Dry powder C. The CCK8 experiment was carried out to explore the inhibitory effect of these three extracts of Citrus aurantium (lyophilized powder A, freeze-dried powder B and freeze-dried powder C) on the proliferation of RKO cells.

实施例5枳实提取物冻干粉抑制人结肠癌细胞RKO细胞增殖的实验研究Example 5 Experimental Study on the Inhibition of the Proliferation of Human Colon Cancer Cell RKO Cells by the Freeze-dried Powder of Citrus Citrus Extract

实验材料Experimental Materials

实验用细胞株Experimental cell line

将人结肠腺癌细胞RKO细胞,置于体积分数为10%FBS的DMEM培养基中常规培养(培养条件:37℃、CO2的体积分数为5%)。The human colon adenocarcinoma RKO cells were routinely cultured in DMEM medium with a volume fraction of 10% FBS (culture conditions: 37° C., CO 2 volume fraction 5%).

受试物储液Test substance stock solution

称取枳实提取物冻干粉(冻干粉A、冻干粉B及冻干粉C),分别溶于PBS缓冲液(GIBCO,货号:10010023),过0.22μm无菌滤膜,4℃储存,给药前用含体积分数为10%FBS的DMEM稀释至工作浓度,实验中所涉及的受试物浓度皆通过福林-酚法进行多酚定量。Weigh the freeze-dried powder of Citrus aurantium extract (lyophilized powder A, freeze-dried powder B and freeze-dried powder C), respectively dissolve in PBS buffer (GIBCO, product number: 10010023), pass through a 0.22 μm sterile filter membrane, 4 ° C It is stored and diluted to the working concentration with DMEM containing 10% FBS by volume fraction before administration. The concentrations of the test substances involved in the experiment are all quantified by the Folin-phenol method.

实验试剂experimental reagent

DMEM培养基(GIBCO 11965-092)、胎牛血清(GIBCO 10099-141-FBS)、Trpsin(GIBCO 25200072)、Penicillin-Streptomycin(GIBCO 15140163)、PBS(GIBCO 10010023)、CCK-8溶液(Dojindo)DMEM medium (GIBCO 11965-092), fetal bovine serum (GIBCO 10099-141-FBS), Trpsin (GIBCO 25200072), Penicillin-Streptomycin (GIBCO 15140163), PBS (GIBCO 10010023), CCK-8 solution (Dojindo)

实验器材experiment equipment

重庆奥特光学倒置显微镜(BDS200),紫外光微孔板检测仪(BioteK Synergy H1),二氧化碳细胞培养箱(Thermo),超净台(苏净安泰),全自动高压灭菌锅(日本SanyoMLS3020),台式电热鼓风干燥箱(上海精密实验设备DHG9123A),冰箱(西门子KG18V21TI),液氮罐(MVE),低速离心机(上海安亭科学仪器KA100)。Chongqing Auto Optical Inverted Microscope (BDS200), UV Microplate Detector (BioteK Synergy H1), Carbon Dioxide Cell Incubator (Thermo), Ultra-clean Bench (Sujing Antai), Automatic Autoclave (SanyoMLS3020, Japan) , desktop electric blast drying oven (Shanghai Precision Experimental Equipment DHG9123A), refrigerator (Siemens KG18V21TI), liquid nitrogen tank (MVE), low-speed centrifuge (Shanghai Anting Scientific Instrument KA100).

实验方法experimental method

RKO细胞用体积分数为10%FBS的DMEM培养基于37℃、体积分数5%CO2条件下进行常规培养(100mm培养皿),当细胞融合至80%时,收集细胞,弃去培养液,用PBS缓冲液洗涤三遍,加入1mL Trpsin-EDTA消化1min,向其中加入2mL完全培养基(DMEM)终止消化反应,吹打细胞后将其转至离心管中,1000rpm离心5min,调整细胞悬液浓度为2.5×104个/mL。RKO cells were cultured in DMEM with a volume fraction of 10% FBS based on 37°C and a volume fraction of 5% CO 2 for routine culture (100mm culture dish). When the cells were fused to 80%, the cells were collected, the culture medium was discarded, and Wash with PBS buffer three times, add 1mL Trpsin-EDTA to digest for 1min, add 2mL complete medium (DMEM) to stop the digestion reaction, pipette the cells and transfer them to a centrifuge tube, centrifuge at 1000rpm for 5min, adjust the concentration of the cell suspension to 2.5×10 4 /mL.

将细胞种入96孔培养板中,每孔加入100μL细胞悬液,将96孔培养板放入37℃、体积分数为5%CO2细胞培养箱中进行培养。The cells were seeded into a 96-well culture plate, 100 μL of cell suspension was added to each well, and the 96-well culture plate was placed in a 37° C., 5% CO 2 cell incubator for culture.

观察细胞生长情况,培养12h后,可长至50-60%,加入100μL枳实冻干粉溶液(冻干粉A、冻干粉B或冻干粉C),继续培养24h。Observe the growth of the cells. After culturing for 12 hours, they can grow to 50-60%. Add 100 μL of citrus citrus lyophilized powder solution (lyophilized powder A, lyophilized powder B or lyophilized powder C), and continue to cultivate for 24 hours.

24h后,吸出孔里全部培养基,更换为100μL无血清培养基,加入10μL CCK-8溶液,置于二氧化碳培养箱(37℃、CO2的体积分数为5%),继续培养2h。在酶标仪450nm处测量各孔的吸光值,每组设定4个复孔。After 24 hours, suck out all the medium in the well, replace it with 100 μL serum-free medium, add 10 μL CCK-8 solution, place in a carbon dioxide incubator (37°C, CO2 volume fraction is 5%), and continue to cultivate for 2 hours. The absorbance of each well was measured at 450 nm in a microplate reader, and 4 replicate wells were set for each group.

结果以药物对细胞的存活率表示:The results are expressed as the survival rate of the drug on the cells:

按照公式计算枳实提取物对人结肠癌RKO细胞增殖的影响。according to The formula was used to calculate the effect of Citrus aurantium extract on the proliferation of human colon cancer RKO cells.

实验分组如下:The experimental groups are as follows:

以多酚(福林酚法测定)定量:Quantification by polyphenols (determination by Folin's phenol method):

实验组a:大孔树脂吸附前的枳实粗提物(冻干粉A);②实验组b:大孔树脂吸附后水溶液中的枳实粗提物(冻干粉B);③实验组c(解吸组):大孔树脂用乙醇解吸出的枳实提取物(冻干粉C);④对照组:RKO细胞和完全培养基(DMEM);⑤空白组:完全培养基(DMEM)。Experimental group a: the crude extract of Citrus aurantium before macroporous resin adsorption (lyophilized powder A); ②experimental group b: the crude extract of Citrus aurantium in aqueous solution after macroporous resin adsorption (lyophilized powder B); ③experimental group c (desorption group): Aurantium citrus extract (freeze-dried powder C) desorbed by macroporous resin with ethanol; ④ control group: RKO cells and complete medium (DMEM); ⑤ blank group: complete medium (DMEM).

统计处理Statistical processing

所有数据均独立平行测定3次,数据结果以平均值±标准差(mean±SD)的形式表示,采用SPSS 24.0软件对试验数据进行统计学分析,以p<0.05为差异具有统计学意义,采用Graphpad prism 6.0软件对数据进行方差分析并作图。All data were independently measured in parallel three times, and the data results were expressed in the form of mean ± standard deviation (mean ± SD). SPSS 24.0 software was used to conduct statistical analysis on the test data, and p<0.05 was regarded as a statistically significant difference. Graphpad Prism 6.0 software was used to analyze the variance of the data and make graphs.

实验结果Experimental results

结果如图1所示,经多酚定量后,水提枳实粗提物的冻干粉A在125μg/mL时能显著抑制RKO细胞增殖;AB-8吸附后剩余的溶液冻干粉B在640μg/mL时能显著抑制RKO细胞增殖;乙醇解吸AB-8吸附的部分冻干粉C在40μg/mL时就能显著抑制RKO细胞增殖,如图2所示,在160μg/mL时可以显著改变RKO细胞形态,促使细胞成团聚集生长。The results are shown in Figure 1. After quantification of polyphenols, the freeze-dried powder A of the crude extract of Citrus aurantium can significantly inhibit the proliferation of RKO cells at 125 μg/mL; the remaining solution freeze-dried powder B after AB-8 adsorption 640 μg/mL can significantly inhibit the proliferation of RKO cells; ethanol desorption AB-8 adsorbed part of the lyophilized powder C can significantly inhibit the proliferation of RKO cells at 40 μg/mL, as shown in Figure 2, can significantly change at 160 μg/mL The morphology of RKO cells promotes the growth of cells in clusters.

此外,枳实粗提物冻干粉A中多酚含量需达到250μg/mL才能抑制50%以上肠癌细胞增殖;经AB-8吸附后剩余溶液的冻干粉B,其多酚含量需达到640μg/mL才能抑制50%以上肠癌细胞增殖;乙醇解吸AB-8的冻干粉C,其多酚含量达到160μg/mL就能抑制50%以上肠癌细胞增殖。In addition, the polyphenol content in the freeze-dried powder A of the crude extract of Citrus aurantii must reach 250 μg/mL to inhibit the proliferation of more than 50% of intestinal cancer cells; 640μg/mL can inhibit more than 50% of intestinal cancer cell proliferation; ethanol desorbed AB-8 freeze-dried powder C, its polyphenol content reaches 160μg/mL can inhibit more than 50% of intestinal cancer cell proliferation.

实验结果表明,经AB-8大孔树脂吸附,并通过无水乙醇解吸这一方法,能有效富集枳实粗提物中抑制肠癌细胞RKO增殖的活性成分。可能是由于枳实粗提物中成分复杂,其中含有能抑制肠癌细胞增殖的活性成分,但是单位多酚浓度下有效物质丰度较低,AB-8是一种具有弱极性的大孔树脂,可用于富集极性较弱的酚类物质。经AB-8吸附并经无水乙醇解吸的枳实活性成分,应当属于极性较弱的酚类,此部分物质具有良好抑制肠癌细胞RKO增殖的功效。The experimental results show that the method of adsorption by AB-8 macroporous resin and desorption by absolute ethanol can effectively enrich the active ingredients in the crude extract of Citrus aurantium which inhibit the proliferation of intestinal cancer cell RKO. It may be due to the complex composition of the crude extract of Citrus aurantium, which contains active ingredients that can inhibit the proliferation of intestinal cancer cells, but the abundance of effective substances per unit polyphenol concentration is low, and AB-8 is a macroporous with weak polarity. Resin, which can be used to enrich less polar phenolic substances. The active components of Aurantium citrus fruit adsorbed by AB-8 and desorbed by absolute ethanol should belong to phenols with weak polarity, and this part of substances has a good effect on inhibiting the proliferation of intestinal cancer cell RKO.

以上实施例仅为本发明较优的实施方式,仅用于解释本发明,而非限制本发明,本领域技术人员在未脱离本发明精神实质下所作的改变、替换、修饰等均应属于本发明的保护范围。The above examples are only preferred implementations of the present invention, and are only used to explain the present invention, rather than limit the present invention. Changes, replacements, modifications, etc. made by those skilled in the art without departing from the spirit of the present invention shall belong to the present invention. protection scope of the invention.

Claims (10)

1. a kind of preparation method with the dried immature fruit of citron orange polyphenol for inhibiting colon-cancer cell proliferation function, which is characterized in that including walking as follows It is rapid:
(1) by dried immature fruit of citron orange grinding and sieving, Immature Orange Fruit is obtained, the Immature Orange Fruit is added to the water, is uniformly mixed, heating carries out Extraction process obtains extracting solution;
(2) step (1) extracting solution is subjected to centrifugal treating, takes supernatant, filters to take filtrate, be concentrated, freeze-drying obtains Freeze-dried powder;
(3) step (2) described freeze-dried powder is added to the water, is uniformly mixed, obtains mixed liquor, mixed liquor is added in macroreticular resin In, adsorption treatment is carried out, suction filtration takes filter residue, and filter residue is added in ethanol solution, is placed in shaking table and carries out desorption processing, solved Imbibition;
(4) by step (3) the stripping liquid suction filtration, filtrate is taken, is concentrated, being freeze-dried described in obtaining, there is inhibition colon-cancer cell to increase Grow the dried immature fruit of citron orange polyphenol of effect.
2. preparation method according to claim 1, which is characterized in that the slot size of step (1) described sieving is 20- 100 mesh;The quality of step (1) described water is 10-20 times of Immature Orange Fruit quality;Described heat extracts the temperature of processing and is 60-80 DEG C, the time that the heating extracts processing is 1-3h.
3. preparation method according to claim 1, which is characterized in that the rate of step (2) described centrifugal treating is 2000- 8000rpm, the time of centrifugal treating are 10-15min, and the temperature of the centrifugal treating is 2-6 DEG C;It is described to be filtered into supernatant Cross the nylon filtering cloth of 60 mesh.
4. preparation method according to claim 1, which is characterized in that the mode of step (2) described concentration includes that rotation is steamed Hair, the temperature of the rotary evaporation are 50-65 DEG C;The freeze-drying is vacuum freeze drying, and the time of freeze-drying is 24- 48h。
5. preparation method according to claim 1, which is characterized in that the quality volume of step (3) freeze-dried powder and water Than for 40-60:1mg/mL;The model of the macroreticular resin includes AB-8, ADS-17, D101 and NKA-9;The macroreticular resin with The mass volume ratio of mixed liquor is 1:10-1:20 g/mL.
6. preparation method according to claim 1, which is characterized in that step (3) described adsorption treatment be in shaking table into Capable, the revolving speed of the shaking table is 50-200 rpm;The time of the adsorption treatment is 3-15h, and the temperature of adsorption treatment is 20- 25℃。
7. preparation method according to claim 1, which is characterized in that the volume fraction of step (3) described ethanol solution is 80%-95%, the mass volume ratio of macroreticular resin and ethanol solution is 0.1g/mL after the adsorption saturation;It is placed in shaking table and carries out The shaking speed of desorption processing is 50-200 rpm;The temperature of the desorption processing is 20-25 DEG C, and the time for desorbing processing is 3- 12h。
8. preparation method according to claim 1, which is characterized in that the mode of step (4) described concentration includes that rotation is steamed Hair.
9. a kind of have the trifoliate orange for inhibiting colon-cancer cell proliferation function as made from the described in any item preparation methods of claim 1-8 Real polyphenol.
10. the dried immature fruit of citron orange polyphenol with inhibition colon-cancer cell proliferation function as claimed in claim 9 inhibits colon-cancer cell to increase in preparation The application in drug grown.
CN201910517901.0A 2019-06-14 2019-06-14 A citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells and its preparation method and application Pending CN110237134A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910517901.0A CN110237134A (en) 2019-06-14 2019-06-14 A citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910517901.0A CN110237134A (en) 2019-06-14 2019-06-14 A citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells and its preparation method and application

Publications (1)

Publication Number Publication Date
CN110237134A true CN110237134A (en) 2019-09-17

Family

ID=67887290

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910517901.0A Pending CN110237134A (en) 2019-06-14 2019-06-14 A citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells and its preparation method and application

Country Status (1)

Country Link
CN (1) CN110237134A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118903242A (en) * 2024-10-09 2024-11-08 广州酒家集团利口福食品有限公司 Efficient extraction method of Gan Ziduo phenol

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101062165A (en) * 2007-06-18 2007-10-31 石任兵 Citrus aurantium total flavone extract and the preparing method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101062165A (en) * 2007-06-18 2007-10-31 石任兵 Citrus aurantium total flavone extract and the preparing method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
S. KUNTS等: "Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines", 《EUROPEAN JOURNAL OF NUTRITION》 *
焦士蓉等: "柑橘属类黄酮生物活性的研究进展", 《西华大学学报.自然科学版》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118903242A (en) * 2024-10-09 2024-11-08 广州酒家集团利口福食品有限公司 Efficient extraction method of Gan Ziduo phenol
CN118903242B (en) * 2024-10-09 2024-11-29 广州酒家集团利口福食品有限公司 Efficient extraction method of Gan Ziduo phenol

Similar Documents

Publication Publication Date Title
CN107412720A (en) A kind of bitter gourd polypeptide compound plant medicine for treating diabetes and preparation method thereof
CN110237134A (en) A citrus citrus polyphenol capable of inhibiting the proliferation of intestinal cancer cells and its preparation method and application
CN112274541B (en) Application of semiliquidambar cathayensis aqueous extract in preparation of antitumor drugs
CN105943569A (en) Method for extracting effective ingredients of green plums
CN101352468A (en) New application of horned melon and its extract in the preparation of antitumor drugs
CN102293251B (en) Cornus officinalis fruit milk
CN106109536B (en) Traditional Chinese medicine composition for neurodegenerative disease or nerve regeneration
CN104491834B (en) Anti-gastric cancer health product containing european bird cherry polysaccharide
CN110101801B (en) Dendrobium officinale extract with anti-gastric cancer effect and preparation method and application thereof
CN102379973B (en) Preparation method and application of effective part of solanaceae physalis plant
CN102579869A (en) Preparation method of traditional Tibetan medicine composition for treating liver diseases
CN115837050A (en) Application of vesicle grass processed product
CN108403941B (en) Traditional Chinese medicine composition for treating pancreatic cancer and preparation method and application thereof
CN110215475A (en) A kind of ramulus cinnamomi polyphenol and the preparation method and application thereof with inhibition colon-cancer cell proliferation activity
CN1243443A (en) Fresh rehmannia root extract for proliferating bifidobacteria and extraction method thereof
CN104523740B (en) A kind of selaginella doederlleini polyoses extract preparation method and applications
CN106074668B (en) Traditional Chinese Medicine Preparations for Neurodegenerative Diseases or Nerve Regeneration
CN110538231A (en) Sophora japonica powder extract and its preparation and application
CN104288169B (en) A kind of flavonoid glycoside compound and its production and use
CN114752585B (en) A kind of walnut green skin anti-tumor active protein and its preparation method and application
CN105031188B (en) The preparation method of Chinese medicine composition and its polysaccharide with attenuation anticancer function
CN104983756B (en) The new application of chenopodium album linn whole plants extract
AU2021100815A4 (en) Oral traditional Chinese medicine (TCM) for treating brain metastasis of lung cancer and brain metastases of other cancers, and preparation method thereof
CN107823245B (en) Application of water extract of taro leaves in reducing lipid deposition in hepatocytes
CN103495002B (en) A kind of antineoplastic Chinese medicine composition and its preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190917